By: J.S., STA
Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir.
The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death. The European Medicines Agency (EMA) recommended the drug for coronavirus treatment on 19 November even if it is not yet registered.